Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to compare the effects of two intrathecally administered drugs:0.5% levobupivacaine and0.75%Ropivacaine in spinal anesthesia


Clinical Trial Description

Bupivacaine is a highly cardiotoxic drug and also produces prolonged motor blockade.The newer drugs levobupivacaine and ropivacaine being comparatively less cardio and neurotoxic are preferred now a days.So, we conducted this prospective, randomized double blind study with an aim of comparing the efficacy and characteristics of these drugs. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02201784
Study type Interventional
Source Aligarh Muslim University
Contact
Status Completed
Phase Phase 4
Start date December 2012
Completion date January 2014

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05234801 - Retrospective Foot and Ankle Data Collection
Recruiting NCT02660658 - Optimal Single Dose Intrathecal Dexmedetomidine for Postoperative Analgesia N/A
Completed NCT03858465 - Comparison of Phenylephrine and Ephedrine in the Treatment of Hemodynamic Disorders After Spinal Anesthesia in the Elderly N/A
Completed NCT03899038 - Minimum Effective Dose of 0.5% Bupivacaine for Ultrasound-guided Spinal Anesthesia Using Taylor's Approach N/A
Completed NCT00988234 - Comparison of Two Position for Ultrasound Guided Lumbar Plexus and Sciatic Nerve Block N/A